APA citáció

Bálint Anita, Farkas Klaudia, Nagy Ferenc, Szepes Zoltán, Szűcs Mónika, Bor Renáta, . . . Molnár Tamás. (2016). Efficacy and safety of adalimumab in ulcerative colitis refractory to conventional therapy in routine clinical practice.

Chicago Style (17th ed.) Citation

Bálint Anita, Farkas Klaudia, Nagy Ferenc, Szepes Zoltán, Szűcs Mónika, Bor Renáta, Rutka Mariann, and Molnár Tamás. Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice. 2016.

MLA idézés

Bálint Anita, et al. Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice. 2016.